Topoisomerase I activity and cellular response to radiation in Chinese hamster cells

International Journal of Radiation Biology

Volumn 70, Issue 3, 1996, Pages 251-259

  Zanier, R ^a   De Salvia, R ^a   Fiore, M ^a   Degrassi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE;

ANIMAL CELL; ARTICLE; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; ENZYME ACTIVITY; MITOSIS INHIBITION; PRIORITY JOURNAL; X IRRADIATION;

ANIMALS; CAMPTOTHECIN; CELL CYCLE; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; FLOW CYTOMETRY;

EID: 0029844444     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096144987     Document Type: Article

References (44)

1. BENJAMIN, R. C. and GILL, D. M., 1980, Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. Journal of Biological Chemistry, 255, 10502-10508.
2. BOOTHMAN, D. A., WANG, M., SCHEA, R., BORROWS, H., STRICKFADEN, S. and OWENS, J., 1992, Post-treatment exposure to camptothecin enhances the lethal effects of X-rays on radioresistant human malignant melanoma cells. International Journal of Radiation Oncology, Biology and Physics, 24, 939-948.
3. BOOTHMAN, D. A., FUKUNAGA, N. and WANG, M., 1994, Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Research, 54, 4618-4626.
4. CHAMPOUX, J. J., 1990, Mechanistic aspects of type-I topoisomerases. In: DNA Topology and its Biological Effects. Edited by: Cozzarelli and Wang (Cold Spring Harbor Laboratory Press), pp. 217-242.
5. COLLINS, A. R., 1993, Mutant rodent cell lines sensitive to ultraviolet light, ionizing radiation and cross linking agents: a comprehensive survey of genetic and biochemical characteristics. Mutation Research, 293, 99-118.
6. CORTES, F., PINERO, J. and ORTIZ, T., 1993, Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases. Mutation Research, 303, 71-76.
7. D'ARPA, P. and LIU, L. F. 1989. Topoisomerase-targeting antitumour drugs. Biochimica et Biophysica Acta, 989, 163-177.
8. DEGRASSI, F., DE SALVIA, R. and BERGHELLA, L., 1993, The production of chromosomal alterations by β-lapachone, an activator of topoisomerase I. Mutation Research, 288, 263-267.
9. DEGRASSI, F., DE SALVIA, R., TANZARELLA, C. and PALITTI, F. 1989, Induction of chromosomal aberrations and SCEs by camptothecin, an inhibitor of mammalian topoisomerase I. Mutation Research, 211, 125-130.
10. DEL BINO, G., SKIERSKI, J. S. and DARZYNKIEWICZ, Z., 1991, The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Experimental Cell Research, 195, 485-491.
11. EVANS, H. J., 1977, Molecular mechanism in the induction of chromosome aberrations. In: Progress in Genetic Toxicology. Edited by: D. Scott, B. A. Bridges and F. H. Sobels (Elsevier/North-Holland, Amsterdam), pp. 57-74.
12. EVANS, H. H., RICANATI, M., HORNG, M. and MENCL, J., 1989, Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains. Mutation Research, 217, 53-63.
13. FALK, S. J. and SMITH, P. J., 1992, DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells. International Journal of Radiation Biology, 61, 749-757.
14. FERRO, A. and OLIVERA, B., 1984, Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. Journal of Biological Chemistry, 259, 547-554.
15. HENNEQUIN, C., GIOCANTI, N., BALOSSO, J. and FAVAUDON, V., 1994, Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells. Cancer Research, 54, 1720-1728.
16. HICKSON, I. D., DAVIES, S. L., DAVIES, S. M. and ROBSON, C. N., 1990, DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases. International Journal of Radiation Biology, 58, 561-568.
17. HORWITZ, S. B., CHANG, C.K. and GROLLMAN, A.P., 1971, Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. Molecular Pharmacology, 7, 632-644.
18. HSIANG, Y.-H., HERTZERB, R., HECHT, S. and LIU, L. F., 1985, Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. Biological Chemistry, 260, 14873-14878.
19. HSIANG, Y.-H., LIHOU, M. G. and LIU, L. F., 1989, Arrest of replication fork by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Research, 49, 5077-5082.
20. ILIAKIS, G., 1991, The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. BioEssays, 13, 641-648.
21. KRUPITZA, G. and CERUTTI, P., 1989, ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6. Biochemistry, 28, 2034-2040.
22. LANZA, A., TORNALETTI, S., STEFANINI, M., EVANS, H., RICANATI, M., ASTALDI RICOTTI, G. and PEDRINI, A., 1993, The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases. Carcinogenesis, 14, 1759-1763.
23. LIU, L. F., 1989, DNA topoisomerase poisons as antitumour drugs. Annual Review of Biochemistry, 58, 351-375.
24. 2 arrest in mammalian cells after irradiation with heavy-ion beams. Radiation Research, 79, 97-112.
25. MATTERN, M. R., HOFMANN, G. A., MCCABE, F. L. and JOHNSON, R. K., 1991, Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864). Cancer Research, 51, 5813-5816.
26. MATTERN, M. R., MONG, S.-M., BARTUS, H. F., MIRABELLI, C. K., CROOKE, S. T. and JOHNSON, R. K., 1987, Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Research, 47, 1793-1798.
27. MOORHEAD, P. S., NOWELL, P. C., MELLMAN W. S., BATTIPS, D. M. and HUNGERFORD, D. A., 1960, Chromosome preparation of leukocyte cultures from human peripheral blood. Experimental Cell Research, 20, 613-616.
28. MUSK, S. R. R. and STEEL, G. G., 1990, The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerases. British Journal of Cancer, 62, 364-367.
29. 2/M delay and cellular radiosensitivity. International Journal of Radiation Biology, 66, 373-379.
30. NG, C. E., BUSSEY, A. M. and RAAPHORST, G. P., 1994, Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines. International Journal of Radiation Biology, 66, 49-57.
31. OBE, G., JOHANNES, C. and SHULTE-FROHLINDE D., 1992, DNA double-strand breaks induced by sparsely ionizing radiation and endonucleases as critical lesions for cell death, chromosomal aberrations, mutations and oncogenic transformation. Mutagenesis, 7, 3-12.
32. PALITTI F., 1993, Mechanism of induction of chromosomal aberrations by inhibitors of DNA topoisomerases. Enviromental and Molecular Mutagenesis, 22, 275-277.
33. PALITTI, F., DEGRASSI, F., DE SALVIA, R., FIORE, M. and TANZARELLA, C., 1989, Inhibitors of DNA Topoisomerases and Chromosome Aberrations. In: Chromosomal Aberrations, Basic and Applied Aspects. Edited by: G. Obe and A.T Natarajan. (Springer-Verlag, Berlin), pp. 50-59.
34. 2 stage of the cell cycle. Mutation Research, 110, 343-350.
35. 2-arrest in Chinese hamster cells treated with anticancer drugs. Journal of National Cancer Institute, 57, 1139-1143.
36. RYAN, A. G., SQUIRES, S., STRUTT, H. L. and JOHNSON, R. T., 1991, Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Research, 19, 3295-3300.
37. SMITH, P. J., MAKINSON, T. A., WATSON, J. V., 1989, Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I. International Journal of Radiation Biology, 55, 217-231.
38. STARON, K., KOWALSKA-LOTH, B., ZABEK, J., CZERWINSKI, R. M. and SZUMIEL, I., 1995, Topoisomerase I is differently phosphorylated in two strains of L5178Y mouse lymphoma cells. Biochimica et Biophisica Acta, 1260, 35-42.
39. Sturelid, S. and Kihlman, B. A., 1978, The temperature and time factors in caffeine potentation of chemically-induced chromosomal aberrations in root tips of Vicia faba. Hereditas, 88, 27-33.
40. SZUMIEL, I., BURACZEWSKA, I., GRADZKA, I. and GASINSKA, A., 1995, Effects of topoisomerase I-targeted drugs on radiation response of L5178Y sublines differentially radiation and drug sensitive. International Journal of Radiation Biology, 67, 441-448.
41. 1. Mutagenesis, 1, 41-44.
42. THACKER, J. and GANESH, A. N., 1990, DNA-break repair, radio-resistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells. Mutation Research, 235, 49-58.
43. cdc2/cyclin B1. Cancer Research, 52, 1823-1829.
44. UCKUN, F. M., STEWART, C. F., REAMAN, G., CHELSTROM, L. M., JIN, J., CHANDRA-LANGLIE, M., WADDICK, K. G., WHITE, J. and EVANS, W. E., 1995, In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells. Blood, 85, 2817-2828.